Original Webinar Date: 08/18/2022

The evolving standards of precision medicine: implications of Tempus abstract findings from the 2022 ASCO® Annual Meeting

Speakers Ezra Cohen, MD, FRCPSC, FASCO
Chief, Division of Hematology-Oncology, UC San Diego Moores Cancer Center

Mary J. Fidler, MD
Medical Oncology Section Chief, Rush Medical Center

Wade T. Iams, MD, MSCI
Assistant Professor of Medicine, Vanderbilt-Ingram Cancer Center

Calvin Chao, MD
SVP, Medical Affairs, Tempus

James L. Chen, MD
SVP, Cancer Informatics, Tempus

Hear panelists Dr. Ezra Cohen of UC San Diego Moores Cancer Center, Dr. Mary J. Fidler of Rush Medical Center and Dr. Wade T. Iams of Vanderbilt-Ingram Cancer Center, discuss which NGS tests should be ordered for optimal patient care. They also delve into various NGS approaches, including the integration of RNA sequencing, concurrent testing using solid tumor and liquid biopsy, and tumor and normal DNA sequencing calculations for TMB.

Related Content

View more